Anti-vasospastic effects of botulinum toxin B pretreatment in animal models

Jeongmin Yoon, Eul Sik Yoon, Byung-Il Lee, Seung Ha Park, Jin Woo Kim

Research output: Contribution to journalArticle

Abstract

Background: Botulinum toxin has been recently known for its vasodilatory effect. The main purpose of our study was to demonstrate the anti-vasospastic effect of botulinum toxin B in animal models. Method: In this prospective experimental rat study, we used 10 male Sprague-Dawley rats. The right and left inguinal areas (femoral vessels) served as the experimental and control groups, respectively. Three days prior to the experimental procedure, botulinum toxin B and normal saline were subcutaneously injected in the experimental and control groups, respectively. After three days, the vascular diameter and flow were measured. Then, phenylephrine was injected, and after one hour the same parameters were measured. Results: The changes in arterial diameter in the experimental and control group were 30.83 ± 10.43% and 40.00 ± 8.61%, respectively. The vein diameter decreased by 22.98 ± 10.08% in the experimental group compared to 49.05 ± 10.08% for the control group. Furthermore, the arterial flow change in the control group was 8.28 ± 2.10% compared to 1.16 ± 0.65% in the experimental group. In addition, the venous flow in the control group decreased by 9.27 ± 2.75% compared to 0.92 ± 0.56% in the experimental group. Both arterial and venous diameters and flows showed statistical significance between the experimental and control groups (p <.05). Conclusions: Our study demonstrated that pretreatment with botulinum toxin B led to significantly reduced change in vascular diameters and flows compared with the control group, supporting the anti-vasospastic effects of botulinum toxin B.

Original languageEnglish
JournalJournal of Plastic Surgery and Hand Surgery
DOIs
Publication statusAccepted/In press - 2018 Jan 1

Fingerprint

Animal Models
Control Groups
Blood Vessels
Botulinum Toxins
rimabotulinumtoxinB
Groin
Phenylephrine
Thigh
Sprague Dawley Rats
Veins

Keywords

  • Botulinum toxin
  • Flap
  • Vasospasm

ASJC Scopus subject areas

  • Surgery

Cite this

@article{69ce3720ae674ff3b9aeae2fe5c7bf15,
title = "Anti-vasospastic effects of botulinum toxin B pretreatment in animal models",
abstract = "Background: Botulinum toxin has been recently known for its vasodilatory effect. The main purpose of our study was to demonstrate the anti-vasospastic effect of botulinum toxin B in animal models. Method: In this prospective experimental rat study, we used 10 male Sprague-Dawley rats. The right and left inguinal areas (femoral vessels) served as the experimental and control groups, respectively. Three days prior to the experimental procedure, botulinum toxin B and normal saline were subcutaneously injected in the experimental and control groups, respectively. After three days, the vascular diameter and flow were measured. Then, phenylephrine was injected, and after one hour the same parameters were measured. Results: The changes in arterial diameter in the experimental and control group were 30.83 ± 10.43{\%} and 40.00 ± 8.61{\%}, respectively. The vein diameter decreased by 22.98 ± 10.08{\%} in the experimental group compared to 49.05 ± 10.08{\%} for the control group. Furthermore, the arterial flow change in the control group was 8.28 ± 2.10{\%} compared to 1.16 ± 0.65{\%} in the experimental group. In addition, the venous flow in the control group decreased by 9.27 ± 2.75{\%} compared to 0.92 ± 0.56{\%} in the experimental group. Both arterial and venous diameters and flows showed statistical significance between the experimental and control groups (p <.05). Conclusions: Our study demonstrated that pretreatment with botulinum toxin B led to significantly reduced change in vascular diameters and flows compared with the control group, supporting the anti-vasospastic effects of botulinum toxin B.",
keywords = "Botulinum toxin, Flap, Vasospasm",
author = "Jeongmin Yoon and Yoon, {Eul Sik} and Byung-Il Lee and Park, {Seung Ha} and Kim, {Jin Woo}",
year = "2018",
month = "1",
day = "1",
doi = "10.1080/2000656X.2018.1523179",
language = "English",
journal = "Journal of Plastic Surgery and Hand Surgery",
issn = "2000-656X",
publisher = "Informa Healthcare",

}

TY - JOUR

T1 - Anti-vasospastic effects of botulinum toxin B pretreatment in animal models

AU - Yoon, Jeongmin

AU - Yoon, Eul Sik

AU - Lee, Byung-Il

AU - Park, Seung Ha

AU - Kim, Jin Woo

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background: Botulinum toxin has been recently known for its vasodilatory effect. The main purpose of our study was to demonstrate the anti-vasospastic effect of botulinum toxin B in animal models. Method: In this prospective experimental rat study, we used 10 male Sprague-Dawley rats. The right and left inguinal areas (femoral vessels) served as the experimental and control groups, respectively. Three days prior to the experimental procedure, botulinum toxin B and normal saline were subcutaneously injected in the experimental and control groups, respectively. After three days, the vascular diameter and flow were measured. Then, phenylephrine was injected, and after one hour the same parameters were measured. Results: The changes in arterial diameter in the experimental and control group were 30.83 ± 10.43% and 40.00 ± 8.61%, respectively. The vein diameter decreased by 22.98 ± 10.08% in the experimental group compared to 49.05 ± 10.08% for the control group. Furthermore, the arterial flow change in the control group was 8.28 ± 2.10% compared to 1.16 ± 0.65% in the experimental group. In addition, the venous flow in the control group decreased by 9.27 ± 2.75% compared to 0.92 ± 0.56% in the experimental group. Both arterial and venous diameters and flows showed statistical significance between the experimental and control groups (p <.05). Conclusions: Our study demonstrated that pretreatment with botulinum toxin B led to significantly reduced change in vascular diameters and flows compared with the control group, supporting the anti-vasospastic effects of botulinum toxin B.

AB - Background: Botulinum toxin has been recently known for its vasodilatory effect. The main purpose of our study was to demonstrate the anti-vasospastic effect of botulinum toxin B in animal models. Method: In this prospective experimental rat study, we used 10 male Sprague-Dawley rats. The right and left inguinal areas (femoral vessels) served as the experimental and control groups, respectively. Three days prior to the experimental procedure, botulinum toxin B and normal saline were subcutaneously injected in the experimental and control groups, respectively. After three days, the vascular diameter and flow were measured. Then, phenylephrine was injected, and after one hour the same parameters were measured. Results: The changes in arterial diameter in the experimental and control group were 30.83 ± 10.43% and 40.00 ± 8.61%, respectively. The vein diameter decreased by 22.98 ± 10.08% in the experimental group compared to 49.05 ± 10.08% for the control group. Furthermore, the arterial flow change in the control group was 8.28 ± 2.10% compared to 1.16 ± 0.65% in the experimental group. In addition, the venous flow in the control group decreased by 9.27 ± 2.75% compared to 0.92 ± 0.56% in the experimental group. Both arterial and venous diameters and flows showed statistical significance between the experimental and control groups (p <.05). Conclusions: Our study demonstrated that pretreatment with botulinum toxin B led to significantly reduced change in vascular diameters and flows compared with the control group, supporting the anti-vasospastic effects of botulinum toxin B.

KW - Botulinum toxin

KW - Flap

KW - Vasospasm

UR - http://www.scopus.com/inward/record.url?scp=85054503532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054503532&partnerID=8YFLogxK

U2 - 10.1080/2000656X.2018.1523179

DO - 10.1080/2000656X.2018.1523179

M3 - Article

JO - Journal of Plastic Surgery and Hand Surgery

JF - Journal of Plastic Surgery and Hand Surgery

SN - 2000-656X

ER -